Role of interleukin-10 in a murine model of dextran sulfate sodium- induced colitis

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 4, 1998, Pages 435-440

  Tomoyose, M ^b   Mitsuyama, K ^a   Ishida, H ^b   Toyonaga, A ^b   Tanikawa, K ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Colitis; Crohn's disease; Cytokines; Dextran sulfate sodium; Interleukin 10; Ulcerative colitis

Indexed keywords

DEXTRAN SULFATE; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; MYELOPEROXIDASE; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COLITIS; COLON; DEXTRAN SULFATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERLEUKIN-1; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031900372     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850171080     Document Type: Article

References (36)

1. Fiocchi C. Cytokines. In: MacDermott R, Stenson W, editors. Inflammatory bowel diseases. New York: Elsevier; 1992. p. 137-62.
2. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994;106: 533-9.
3. Reinecker H-C, Schreiber S, Stenson WF, MacDermott RP. The role of the mucosal immune system in ulcerative colitis and Crohn's disease. In: Ogra PL, Strober W, Mestecky J, McGhee JR, Lamm ME, Bienenstock J, editors. Handbook of mucosal immunology: San Diego (CA): Academic Press; 1994. p. 439-56.
4. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587-95.
5. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, et al. Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818-26.
6. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1β by mononuclear cells isolated from mucosa with active ulcerative colitis and Crohn's disease. Gut 1989; 30:835-8.
7. MacDonald TT, Mutchings P, Choy M-Y, Murch S, Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990;81:301-5.
8. Mitsuyama K, Sasaki E, Toyonaga A, Ikeda H, Tsuruta O, Irie A, et al. Colonic mucosal interleukin-6 in inflammatory bowel disease. Digestion 1991;50:104-11.
9. Mitsuyama K, Toyonaga A, Sasaki E, Watanabe H, Tateishi H, Nishiyama T, et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1994;96:432-6.
10. Nishiyama T, Mitsuyama K, Toyonaga A, Sasaki E, Tanikawa K. Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel diseae. Digestion 1994;55:368-73.
11. van Dullemen HM, van Devenrter SJH, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-35.
12. Schreiber S, Heinig T, Thiele H-G, Raedler A. Immunoregulatory role of interleukin 10 in patient with inflammatory bowel disease. Gastroenterology 1995;108:1434-44
13. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
14. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
15. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
16. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-α and interleukin-10. J Biol Chem 1992;267:23301-8.
17. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992;13:198-200.
18. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
19. Herfarth HH, Mohanty SP, Tonkonoogy S, Sartor RB. Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut 1996;39:836-45.
20. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the Induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
21. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994;107:1643-52.
22. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-50.
23. Wanidworanun C, Strober W. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J Immunol 1993;151:6853-61.
24. Kojouharoff G, Hans W, Obermeier F, Schölmerich J, Andus T, Männel DN, et al. Reduction of inflammatory score by neutralization of tumor necrosis factor alpha (TNF) and not interleukin-1 (IL-1) in experimental dextrane sulfate (DSS-) induced chronic colitis. Gastroenterology 1996;110:A940.
25. Neurath MF, Kollias G, Duchamann R, Fuss I, Strober W, zum Büschenfelde KHM. Effects of antibodies to TNFα on acute and chronic experimental colitis in mice. Gastroenterology 1996; 110:A979.
26. Cominelli F, Nast CC, Duchini A, Lee M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 1992;103:65-71.
27. Thomas TK, Will PC, Srivastava A, Wilson CL, Harbison M, Little J, et al. Evaluation of an interleukin-1 receptor antagonist in the rat acetic acid-induced colitis model. Agents Actions 1991;34:187-90.
28. McCall RD, Haskill S, Zimmermann EM, Lund PK, Thompson RC, Sartor RB. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology 1994;106:960-72.
29. Tateishi H, Mitsuyama K, Toyonaga A, Tomoyose M, Tanikawa K. Role of cytokines in experimental colitis: Relation to intestinal permeability. Digestion 1997;58:271-81.
30. Harada K, Toyonaga A, Mitsuyama K, Sasaki E, Tanikawa K. Role of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in rat experimental colitis. Digestion 1994;55:179-84.
31. Gérard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547-50.
32. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177: 1205-8.
33. van Laethem J-L, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T, et al. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995;108:1917-22.
34. Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 1989;86:3803-7.
35. Malefyt RW, Figdor CG, Huijbens R, Peterson SM, Bennett B, Culpepper J, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFNγ or IL-10. J Immunol 1993;151:6370-81.
36. Attisano L, Wrana JL, Casillas FF, Massagué J. TGF-beta receptor and actions. Biochim Biohys Acta 1994;1222:71-80.